FDA data dashboards & analytics BPA

Ended Awarded Last action

Contract number
75F40124F19002
Awardee
Awarding agency
Obligated
$435,570

Award facts

Contract value 100% obligated
$435,570.21 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20903, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 · Decommission the CP dashboard. $35,620
Other Administrative Action P00001 · The purpose of this modification is to change to labor hour $0
Original award $399,950

About this award

Booz Allen Hamilton Inc. received a contract award from the Food and Drug Administration (FDA) on February 28, 2024, to decommission the CP Dashboard as part of the FDA Data Dashboards & Analytics Blanket Purchase Agreement (BPA). The contract is valued at $435,570.21 with a completion date of April 16, 2025, and is structured as a labor-hours BPA call under the General Services Administration's Multiple Award Schedule. Work will be performed at the FDA's Silver Spring, Maryland location.

This award reflects the FDA's efforts to modernize its data analytics infrastructure by retiring legacy dashboard systems. Booz Allen Hamilton, a large business prime contractor with no small business set-aside designation, brings substantial experience supporting the FDA across numerous task orders related to electronic submissions, regulatory science optimization, and data management initiatives. The engagement demonstrates the company's ongoing role in supporting the agency's digital transformation initiatives, leveraging its extensive capabilities in data analytics, systems engineering, and IT infrastructure modernization across federal civilian agencies.

Quick answers

Who was awarded contract 75F40124F19002?

75F40124F19002 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on February 28, 2024.

How much is contract 75F40124F19002 worth?

The government has obligated $435,570 on 75F40124F19002.

Is contract 75F40124F19002 an order under another contract?

Yes. 75F40124F19002 is a BPA call under GS35F386DA-75F40123A00019, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40124F19002 competed?

The extent of competition for 75F40124F19002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award